Stockscreener 앱 받기
1.30
0.78%
0.01
전일 마감가:
$1.29
열려 있는:
$1.28
하루 거래량:
915.71K
Relative Volume:
0.54
시가총액:
$496.59M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.3684
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
+3.17%
1개월 성능:
+0.00%
6개월 성능:
+8.33%
1년 성능:
-33.67%
1일 변동 폭
$1.275
$1.35
1주일 범위
$1.20
$1.35
52주 변동 폭
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.30 | 492.77M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
133.28 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.09 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.87 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.99 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.91 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Aug Opening: Will Standard BioTools Inc. face regulatory challengesWeekly Gains Summary & Long-Term Safe Investment Ideas - khodrobank.com
Is a relief rally coming for Standard BioTools Inc. holders2025 Growth vs Value & Free Community Supported Trade Ideas - Newser
Standard BioTools Inc. stock daily chart insightsJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser
What to expect from Standard BioTools Inc. in the next 30 daysMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Is Standard BioTools Inc. still worth holding after the dip2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Sector ETF performance correlation with Standard BioTools Inc.Weekly Trade Report & Entry Point Confirmation Alerts - Newser
Is Standard BioTools Inc. stock reversal real or fakeJuly 2025 Breakouts & Real-Time Volume Analysis - Newser
Detecting price anomalies in Standard BioTools Inc. with AI2025 Institutional Moves & Weekly High Potential Alerts - Newser
Does Standard BioTools Inc. qualify in momentum factor screeningProduct Launch & Accurate Buy Signal Alerts - Newser
Can a trend reversal in Standard BioTools Inc. lead to recoveryJuly 2025 Selloffs & Smart Swing Trading Techniques - Newser
Is Standard BioTools Inc. a play on infrastructure spendingEarnings Recap Report & Growth-Oriented Investment Plans - khodrobank.com
Strategies to average down on Standard BioTools Inc.Market Activity Recap & Stepwise Entry and Exit Trade Signals - Newser
Best data tools to analyze Standard BioTools Inc. stockJuly 2025 Review & Daily Technical Forecast Reports - Newser
Visualizing Standard BioTools Inc. stock with heatmapsQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Sentiment analysis tools applied to Standard BioTools Inc.July 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
Will Standard BioTools Inc. stock recover after recent drop2025 Big Picture & Growth Oriented Trade Recommendations - Newser
Applying Wyckoff theory to Standard BioTools Inc. stockJuly 2025 Earnings & High Win Rate Trade Alerts - Newser
Regression analysis insights on Standard BioTools Inc. performance2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser
Is Standard BioTools Inc. likely to announce a buybackJuly 2025 Recap & AI Driven Stock Price Forecasts - khodrobank.com
Standard BioTools Inc. stock chart pattern explainedJuly 2025 Momentum & Fast Entry High Yield Stock Tips - Newser
Using AI based signals to follow Standard BioTools Inc.Market Activity Recap & Weekly Momentum Picks - Newser
Standard BioTools to consolidate R&D operations, announces $3.6 million in restructuring costs - Investing.com
Standard BioTools Announces Strategic Restructuring Plan - TipRanks
Is Standard BioTools Inc.’s ROE strong enoughJuly 2025 Setups & Real-Time Market Sentiment Reports - khodrobank.com
Published on: 2025-09-03 04:31:17 - Newser
How to monitor Standard BioTools Inc. with trend dashboardsMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Has Standard BioTools Inc. formed a bullish divergenceCPI Data & Expert Approved Momentum Ideas - Newser
Ranking Standard BioTools Inc. among high performing stocks via toolsWeekly Profit Summary & Step-by-Step Swing Trade Plans - Newser
Full technical analysis of Standard BioTools Inc. stockJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Key metrics from Standard BioTools Inc.’s quarterly dataJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
Analyzing recovery setups for Standard BioTools Inc. investorsJuly 2025 Movers & Weekly Chart Analysis and Guides - Newser
Is Standard BioTools Inc. vulnerable to short sellersTrade Ideas & Reliable Trade Execution Plans - khodrobank.com
Using Python tools to backtest Standard BioTools Inc. strategiesWall Street Watch & Verified Momentum Watchlists - Newser
What moving averages say about Standard BioTools Inc.Watch List & Fast Moving Stock Trade Plans - Newser
Does Standard BioTools Inc. meet Warren Buffett’s criteria2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - khodrobank.com
Is Standard BioTools Inc. stock forming a cup and handleJuly 2025 Snapshot & Low Risk High Win Rate Picks - khodrobank.com
What is Standard BioTools Inc.’s market positionPortfolio Value Summary & Verified Short-Term Plans - khodrobank.com
Will Standard BioTools Inc. face regulatory challengesJuly 2025 Earnings & Detailed Earnings Play Alerts - khodrobank.com
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Standard Biotools Inc 주식 (LAB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | Director |
Aug 25 '25 |
Buy |
1.24 |
200,000 |
248,180 |
60,150,000 |
| Casdin Partners Master Fund, L | Director |
Aug 26 '25 |
Buy |
1.26 |
125,000 |
157,938 |
60,275,000 |
| Casdin Partners Master Fund, L | Director |
Aug 15 '25 |
Buy |
1.22 |
150,000 |
183,210 |
59,750,000 |
| Casdin Partners Master Fund, L | Director |
Aug 14 '25 |
Buy |
1.21 |
133,220 |
161,543 |
59,600,000 |
| Casdin Partners Master Fund, L | Director |
Aug 13 '25 |
Buy |
1.31 |
75,000 |
98,280 |
59,466,780 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 23 '25 |
Sale |
0.94 |
1,428 |
1,344 |
930,286 |
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
| Egholm Michael | President & CEO |
May 23 '25 |
Sale |
0.94 |
5,473 |
5,150 |
2,741,191 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 22 '25 |
Sale |
1.00 |
1,355 |
1,358 |
931,714 |
| Egholm Michael | President & CEO |
May 22 '25 |
Sale |
1.00 |
5,116 |
5,126 |
2,746,664 |
0.56%
0.82%
자본화:
|
볼륨(24시간):